Logo image of LFWD

LIFEWARD LTD (LFWD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:LFWD - IL0011331076 - Common Stock

0.6554 USD
-0.03 (-4.66%)
Last: 1/14/2026, 8:00:03 PM
0.67 USD
+0.01 (+2.23%)
After Hours: 1/14/2026, 8:00:03 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LFWD. LFWD was compared to 185 industry peers in the Health Care Equipment & Supplies industry. LFWD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LFWD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year LFWD has reported negative net income.
  • LFWD had a negative operating cash flow in the past year.
  • In the past 5 years LFWD always reported negative net income.
  • LFWD had a negative operating cash flow in each of the past 5 years.
LFWD Yearly Net Income VS EBIT VS OCF VS FCFLFWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • LFWD's Return On Assets of -127.62% is on the low side compared to the rest of the industry. LFWD is outperformed by 85.41% of its industry peers.
  • LFWD's Return On Equity of -231.80% is on the low side compared to the rest of the industry. LFWD is outperformed by 74.05% of its industry peers.
Industry RankSector Rank
ROA -127.62%
ROE -231.8%
ROIC N/A
ROA(3y)-52.11%
ROA(5y)-43.2%
ROE(3y)-76.61%
ROE(5y)-60.74%
ROIC(3y)N/A
ROIC(5y)N/A
LFWD Yearly ROA, ROE, ROICLFWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

1.3 Margins

  • The Gross Margin of LFWD (37.49%) is worse than 70.27% of its industry peers.
  • In the last couple of years the Gross Margin of LFWD has declined.
  • The Profit Margin and Operating Margin are not available for LFWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.02%
GM growth 5Y-10.56%
LFWD Yearly Profit, Operating, Gross MarginsLFWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

5

2. Health

2.1 Basic Checks

  • LFWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for LFWD has been increased compared to 1 year ago.
  • Compared to 5 years ago, LFWD has more shares outstanding
  • LFWD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LFWD Yearly Shares OutstandingLFWD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
LFWD Yearly Total Debt VS Total AssetsLFWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -17.12, we must say that LFWD is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -17.12, LFWD is doing worse than 87.03% of the companies in the same industry.
  • LFWD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -17.12
ROIC/WACCN/A
WACC8.6%
LFWD Yearly LT Debt VS Equity VS FCFLFWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 1.92 indicates that LFWD should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.92, LFWD is not doing good in the industry: 63.24% of the companies in the same industry are doing better.
  • LFWD has a Quick Ratio of 1.13. This is a normal value and indicates that LFWD is financially healthy and should not expect problems in meeting its short term obligations.
  • LFWD has a worse Quick ratio (1.13) than 71.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.13
LFWD Yearly Current Assets VS Current LiabilitesLFWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

  • LFWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.30%, which is quite impressive.
  • The Revenue has decreased by -2.02% in the past year.
  • Measured over the past years, LFWD shows a very strong growth in Revenue. The Revenue has been growing by 39.41% on average per year.
EPS 1Y (TTM)25.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)-2.02%
Revenue growth 3Y62.63%
Revenue growth 5Y39.41%
Sales Q2Q%1.09%

3.2 Future

  • Based on estimates for the next years, LFWD will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.57% on average per year.
  • The Revenue is expected to grow by 40.19% on average over the next years. This is a very strong growth
EPS Next Y51.63%
EPS Next 2Y36.58%
EPS Next 3Y25.45%
EPS Next 5Y18.57%
Revenue Next Year-2.52%
Revenue Next 2Y23.38%
Revenue Next 3Y33.2%
Revenue Next 5Y40.19%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
LFWD Yearly Revenue VS EstimatesLFWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
LFWD Yearly EPS VS EstimatesLFWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -100 -200 -300 -400

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LFWD. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LFWD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFWD Price Earnings VS Forward Price EarningsLFWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LFWD Per share dataLFWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

  • LFWD's earnings are expected to grow with 25.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.58%
EPS Next 3Y25.45%

More info and screens

0

5. Dividend

5.1 Amount

  • LFWD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

LIFEWARD LTD

NASDAQ:LFWD (1/14/2026, 8:00:03 PM)

After market: 0.67 +0.01 (+2.23%)

0.6554

-0.03 (-4.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14
Earnings (Next)03-05
Inst Owners4.65%
Inst Owner ChangeN/A
Ins Owners2.13%
Ins Owner Change26.89%
Market Cap11.99M
Revenue(TTM)24.50M
Net Income(TTM)-29.57M
Analysts82.5
Price Target5.27 (704.09%)
Short Float %9.79%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.82%
Min EPS beat(2)-86.44%
Max EPS beat(2)8.8%
EPS beat(4)1
Avg EPS beat(4)-28.68%
Min EPS beat(4)-86.44%
Max EPS beat(4)8.8%
EPS beat(8)2
Avg EPS beat(8)-17.81%
EPS beat(12)3
Avg EPS beat(12)-15.18%
EPS beat(16)3
Avg EPS beat(16)-24.07%
Revenue beat(2)0
Avg Revenue beat(2)-9.96%
Min Revenue beat(2)-16.17%
Max Revenue beat(2)-3.76%
Revenue beat(4)0
Avg Revenue beat(4)-9.94%
Min Revenue beat(4)-16.17%
Max Revenue beat(4)-3.76%
Revenue beat(8)0
Avg Revenue beat(8)-10.39%
Revenue beat(12)2
Avg Revenue beat(12)-10%
Revenue beat(16)2
Avg Revenue beat(16)-18.6%
PT rev (1m)0%
PT rev (3m)-6.06%
EPS NQ rev (1m)3.7%
EPS NQ rev (3m)24.63%
EPS NY rev (1m)-1.29%
EPS NY rev (3m)14.83%
Revenue NQ rev (1m)1.86%
Revenue NQ rev (3m)1.86%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 1.5
EV/EBITDA N/A
EPS(TTM)-1.86
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.94
FCFYN/A
OCF(TTM)-0.94
OCFYN/A
SpS1.34
BVpS0.7
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -127.62%
ROE -231.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.49%
FCFM N/A
ROA(3y)-52.11%
ROA(5y)-43.2%
ROE(3y)-76.61%
ROE(5y)-60.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.02%
GM growth 5Y-10.56%
F-Score4
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.41%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.13
Altman-Z -17.12
F-Score4
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)5.59%
Cap/Depr(5y)12.01%
Cap/Sales(3y)0.35%
Cap/Sales(5y)0.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y51.63%
EPS Next 2Y36.58%
EPS Next 3Y25.45%
EPS Next 5Y18.57%
Revenue 1Y (TTM)-2.02%
Revenue growth 3Y62.63%
Revenue growth 5Y39.41%
Sales Q2Q%1.09%
Revenue Next Year-2.52%
Revenue Next 2Y23.38%
Revenue Next 3Y33.2%
Revenue Next 5Y40.19%
EBIT growth 1Y16.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.06%
OCF growth 3YN/A
OCF growth 5YN/A

LIFEWARD LTD / LFWD FAQ

Can you provide the ChartMill fundamental rating for LIFEWARD LTD?

ChartMill assigns a fundamental rating of 3 / 10 to LFWD.


Can you provide the valuation status for LIFEWARD LTD?

ChartMill assigns a valuation rating of 1 / 10 to LIFEWARD LTD (LFWD). This can be considered as Overvalued.


What is the profitability of LFWD stock?

LIFEWARD LTD (LFWD) has a profitability rating of 0 / 10.


How financially healthy is LIFEWARD LTD?

The financial health rating of LIFEWARD LTD (LFWD) is 5 / 10.


What is the expected EPS growth for LIFEWARD LTD (LFWD) stock?

The Earnings per Share (EPS) of LIFEWARD LTD (LFWD) is expected to grow by 51.63% in the next year.